Cryptococcosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Medical | ==Medical Therapy== | ||
The standard regimen of treatment in non-AIDS patients [[intravenous]] [[Amphotericin B]] combined with [[Wiktionary:oral|oral]] [[flucytosine]]. | The standard regimen of treatment in non-AIDS patients [[intravenous]] [[Amphotericin B]] combined with [[Wiktionary:oral|oral]] [[flucytosine]]. | ||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Fungal diseases]] | |||
[[Category:Disease]] | |||
Revision as of 13:55, 24 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Cryptococcosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptococcosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Cryptococcosis medical therapy |
|
Risk calculators and risk factors for Cryptococcosis medical therapy |
Overview
Medical Therapy
The standard regimen of treatment in non-AIDS patients intravenous Amphotericin B combined with oral flucytosine.
AIDS patients often have a reduced response to Amphotericin B and flucytosine, therefore after initial treatment as above, oral fluconazole can be used.